WT

Whitehawk Therapeutics Inc

WHWK·NASDAQ

$4.18

+6.1%
HealthcareBiotechnology

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

At a Glance

Live Snapshot
Market Cap$206.71M
EPS-0.3300
P/E Ratio-7.27
Earnings Date08/06/2026

whwk

Short Term Debt

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

WT

Whitehawk Therapeutics Inc Competitors Analysis of Short Term Debt

WHWK · NASDAQ
CompanyShort Term Debt
CAGR 3Y
CAGR 5Y
CAGR 10Y
0.00
N/AN/AN/A 
0.00
N/AN/AN/A
112.06K
N/AN/AN/A
0.00
N/AN/AN/A
1.47M
N/AN/A15.8%
0.00
N/AN/AN/A
5.10M
23.2%-20.2%N/A
316.00K
N/A-45.5%N/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
WT

Whitehawk Therapeutics Inc Fair Value Envelope

WHWK · NASDAQ

Our analysis suggests that WHWK has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.18, this represents a potential HIDDEN relative to our calculated worth for Whitehawk Therapeutics Inc.

Intrinsic Value
Current Price: $4.18